M&A: Page 2
-
Courtesy of Cook Medical
Cook Medical to sell reproductive health business to private equity firm
Astorg intends to combine the Cook assets with Hamilton Thorne, another reproductive health business it plans to buy.
By Nick Paul Taylor • July 23, 2024 -
Permission granted by Nasdaq
Diabetes device firm Embecta considers sale: Financial Times
Two years after Embecta spun out of BD, the firm is now exploring a potential sale, the Financial Times reported.
By Elise Reuter • July 22, 2024 -
Peter Macdiarmid via Getty Images
Dental implant maker Osstem in talks to acquire Zimvie: report
Bloomberg first reported M&A rumors in June when Zimvie was approached about a takeover.
By Elise Reuter • July 19, 2024 -
Stringer via Getty Images
GE Healthcare to buy AI software from Intelligent Ultrasound for $51M
After purchasing Caption Health last year, GE Healthcare plans to add another artificial intelligence acquisition to the company.
By Nick Paul Taylor • July 19, 2024 -
Courtesy of Edwards Lifesciences
Edwards to acquire Innovalve, stake in Affluent Medical
The heart valve specialist said in a federal filing that it expects to pay $300 million in cash for Innovalve Bio Medical when the deal closes.
By Susan Kelly • July 15, 2024 -
Courtesy of Illumina
Illumina buys Fluent Biosciences, adding single-cell analysis tech
Fluent’s kits compete with products from companies including 10x Genomics, an Illumina partner.
By Nick Paul Taylor • July 10, 2024 -
Courtesy of Masimo
Masimo offered up to $950M for consumer business
Final terms of the deal are still being discussed, and Masimo said it plans to negotiate a higher price.
By Nick Paul Taylor • July 9, 2024 -
saengsuriya13 via Getty Images
Baxter considers sale of kidney care unit to PE firm: WSJ
Carlyle Group could reportedly pay more than $4 billion for Baxter’s Vantive business.
By Elise Reuter • July 8, 2024 -
Courtesy of Quest Diagnostics
Quest to buy Lifelabs for $985M
Buying the Canadian laboratory company opens a new front in Quest’s rivalry with Labcorp and marks its third takeover in as many months.
By Nick Paul Taylor • July 8, 2024 -
Zorica Nastasic via Getty Images
Alcon buys Belkin Vision for $81M upfront
Alcon will gain access to a laser treatment for glaucoma that it plans to sell in the U.S. by the end of the year.
By Nick Paul Taylor • July 3, 2024 -
Jajah-sireenut via Getty Images
Merit Medical pays Endogastric $105M for acid reflux treatment
Merit expects the device to add around $30 million in annual sales.
By Nick Paul Taylor • July 2, 2024 -
Mario Tama/Getty via Getty Images
Medtech M&A may pick up after mixed start to 2024: analysts
The annual number of medtech acquisitions is on course to slump to its lowest level since 2017, according to Needham.
By Nick Paul Taylor • July 1, 2024 -
Peter Macdiarmid via Getty Images
Zimvie mulls sale after takeover approaches: Bloomberg
Zimvie is reportedly working with an adviser to assess its options after strategic investors and industry players showed interest in a deal.
By Nick Paul Taylor • June 26, 2024 -
Courtesy of Boston Scientific
Boston Scientific buys Silk Road Medical for $1.26B
Silk Road developed a minimally invasive procedure to prevent stroke in patients with carotid artery disease.
By Susan Kelly • June 18, 2024 -
Courtesy of Grail
Illumina board approves Grail spinoff
Leerink Partners analyst Puneet Souda said Grail, with a cash burn of $532 million in 2023, is likely to remain “a cautionary tale in diagnostics for years to come.”
By Susan Kelly • June 4, 2024 -
skynesher via Getty Images
Stryker inks Artelon buyout to join Zimmer in soft tissue space
BTIG analysts said the takeover could serve as a "defensive mechanism against peers who have been growing rapidly in the space.”
By Nick Paul Taylor • June 4, 2024 -
Permission granted by Becton Dickinson
BD to buy Edwards’ critical care unit for $4.2B
Edwards will sell the business rather than pursue its original strategy announced in December to spin off the group.
By Ricky Zipp • June 3, 2024 -
Natalie Meepian via Getty Images
Medtech venture capital investing rebounded in Q1
Pitchbook analysts are cautiously optimistic that the funding pickup will continue despite uncertainty about interest rates, heightened regulatory scrutiny and the presidential election.
By Susan Kelly • June 3, 2024 -
Nastassia Samal via Getty Images
Surmodics agrees to $627M private equity buyout
Surmodics will go private when the transaction closes, which is expected in the second half of the year.
By Ricky Zipp • May 31, 2024 -
Maks_Lab via Getty Images
Stereotaxis inks APT buyout to gain catheters for surgical robots
The partners are developing a robotically steered diagnostic catheter for use with Stereotaxis’ cardiovascular robots.
By Nick Paul Taylor • May 16, 2024 -
Courtesy of Samsung
Samsung Medison to buy AI ultrasound company Sonio
Sonio’s software uses deep learning to improve image quality. Its software will remain compatible with all ultrasound machines, the company said.
By Elise Reuter • May 8, 2024 -
Courtesy of Quest Diagnostics
Quest to ramp up AI capabilities with purchase of PathAI’s diagnostic lab
PathAI is selling its diagnostics assets, including a Tennessee laboratory, but will continue to support its biopharmaceutical customers.
By Nick Paul Taylor • May 2, 2024 -
Nastassia Samal via Getty Images
Medline to buy Ecolab’s surgical products for nearly $1B
The medical products supplier will acquire Ecolab’s sterile drapes and fluid temperature management systems.
By Susan Kelly • May 1, 2024 -
Courtesy of Endomagnetics
Hologic to buy Endomagnetics for $310M
Endomagnetics, which makes guidance technology for breast cancer surgery, brought in about $35 million in revenue last year.
By Elise Reuter • April 30, 2024 -
Courtesy of Labcorp
Labcorp to acquire Invitae’s assets for $239M
William Blair analyst Andrew Brackmann said Labcorp is being aggressive in its M&A strategy, after announcing last month it would buy several of Bioreference Health’s testing businesses.
By Susan Kelly • April 25, 2024
Previous
